Cellular biomolecules (Photodynamic therapy targets)

Cellular biomolecules in illuminated tissue refers to the collective substrates—primarily lipids, proteins, and nucleic acids—that are chemically modified and damaged by reactive oxygen species (ROS) during photodynamic therapy (PDT). This process begins when a photosensitizing drug is excited by a specific wavelength of light, leading to the production of singlet oxygen or free radicals from molecular oxygen via Type II and Type I photochemical reactions (Dougherty et al., 1998, J Natl Cancer Inst). These ROS are highly reactive and have a short diffusion distance, causing localized destruction of cellular membranes through lipid peroxidation and the inactivation of critical enzymes through protein oxidation (Castano et al., 2004, Nat Rev Cancer). In a clinical context, this mechanism is exploited to induce targeted cell death in tumors and abnormal vasculature, such as in age-related macular degeneration or actinic keratosis (Agostinis et al., 2011, CA Cancer J Clin). Because the damage is mediated by short-lived ROS, the therapeutic effect is highly localized to the area of light illumination, though systemic photosensitivity remains a primary safety concern for patients (Dolmans et al., 2003, Nat Rev Cancer). This approach is distinct from traditional pharmacology as the therapeutic effect is achieved through the broad destruction of cellular architecture rather than the modulation of a specific protein receptor or enzyme.

Other names

ROS targetsPhotodynamic therapy substratesSinglet oxygen targetsCellular components in PDTOxidative stress substrates

Generation of reactive oxygen species (ROS), primarily singlet oxygen, via light activation of a photosensitizer (Type II reaction) or radical generation (Type I reaction), leading to the non-specific oxidation and destruction of lipids, proteins, and nucleic acids.